| Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25 (OH) D] to vitamin D supplementation L Fu, F Yun, M Oczak, BYL Wong, R Vieth, DEC Cole Clinical biochemistry 42 (10-11), 1174-1177, 2009 | 273 | 2009 |
| The ratio of serum 24, 25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 is predictive of 25-hydroxyvitamin D3 response to vitamin D3 supplementation D Wagner, HE Hanwell, K Schnabl, M Yazdanpanah, S Kimball, L Fu, ... The Journal of steroid biochemistry and molecular biology 126 (3-5), 72-77, 2011 | 201 | 2011 |
| Common variants of the vitamin D binding protein gene and adverse health outcomes S Malik, L Fu, DJ Juras, M Karmali, BYL Wong, A Gozdzik, DEC Cole Critical reviews in clinical laboratory sciences 50 (1), 1-22, 2013 | 197 | 2013 |
| Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L (−) SddC (3TC) resistance L Fu, YC Cheng Biochemical pharmacology 55 (10), 1567-1572, 1998 | 169 | 1998 |
| Association of vitamin D binding protein (VDBP) polymorphisms and serum 25 (OH) D concentrations in a sample of young Canadian adults of different ancestry A Gozdzik, J Zhu, BYL Wong, L Fu, DEC Cole, EJ Parra The Journal of steroid biochemistry and molecular biology 127 (3-5), 405-412, 2011 | 128 | 2011 |
| Vitamin D binding protein is a key determinant of 25‐hydroxyvitamin D levels in infants and toddlers TO Carpenter, JH Zhang, E Parra, BK Ellis, C Simpson, WM Lee, J Balko, ... Journal of Bone and Mineral Research 28 (1), 213-221, 2013 | 122 | 2013 |
| Synthesis and antiviral activity of helioxanthin analogues H Yeo, Y Li, L Fu, JL Zhu, EA Gullen, GE Dutschman, Y Lee, R Chung, ... Journal of medicinal chemistry 48 (2), 534-546, 2005 | 104 | 2005 |
| Sensitivity of L-(-) 2′, 3′-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues L Fu, SH Liu, YC Cheng Biochemical pharmacology 57 (12), 1351-1359, 1999 | 84 | 1999 |
| The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study A Leong, W Rehman, Z Dastani, C Greenwood, N Timpson, L Langsetmo, ... PLoS Medicine 11 (10), e1001751, 2014 | 83 | 2014 |
| Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort M Moridani, L Fu, R Selby, F Yun, T Sukovic, B Wong, DEC Cole Clinical biochemistry 39 (6), 606-612, 2006 | 76 | 2006 |
| Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine-and penciclovir-resistant virus L Fu, YC Cheng Antimicrobial agents and chemotherapy 44 (12), 3402-3407, 2000 | 70 | 2000 |
| Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative Y Li, L Fu, H Yeo, JL Zhu, CK Chou, YH Kou, SF Yeh, E Gullen, D Austin, ... Antiviral Chemistry and Chemotherapy 16 (3), 193-201, 2005 | 59 | 2005 |
| In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations Z Dastani, C Berger, L Langsetmo, L Fu, BYL Wong, S Malik, D Goltzman, ... Journal of Bone and Mineral Research 29 (2), 494-499, 2014 | 53 | 2014 |
| Cardiac troponin testing in the acute care setting: Ordering, reporting, and high sensitivity assays-An update from the Canadian society of clinical chemists (CSCC) PA Kavsak, LC Allen, FS Apple, RA Booth, PC Chan, E Delvin, A Fraser, ... Clinical biochemistry 44 (16), 1273-1277, 2011 | 39 | 2011 |
| Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic AY Shuen, BYL Wong, L Fu, R Selby, DEC Cole Clinical biochemistry 45 (6), 397-401, 2012 | 29 | 2012 |
| Stage dependence, cell-origin independence, and prognostic capacity of serum glycan fucosylation, β1–4 branching, β1–6 branching, and α2–6 sialylation in cancer S Ferdosi, DS Rehder, P Maranian, EP Castle, TH Ho, HI Pass, ... Journal of proteome research 17 (1), 543-558, 2018 | 28 | 2018 |
| Inhibition and treatment of Hepatitis B virus and Flavivirus by Helioxanthin and its analogs YC Cheng, CK Chou, L Fu, YH Kuo, SF Yeh, J Zhu, Y Zhu US Patent 6,306,899, 2001 | 20 | 2001 |
| Characterization of additional vitamin D binding protein variants L Fu, CR Borges, DS Rehder, BYL Wong, R Williams, TO Carpenter, ... The Journal of Steroid Biochemistry and Molecular Biology 159, 54-59, 2016 | 12 | 2016 |
| Relationship of total and free 25-hydroxyvitamin D to biomarkers and metabolic indices in healthy children CA Simpson, JH Zhang, D Vanderschueren, L Fu, TC Pennestri, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), e1631-e1640, 2020 | 10 | 2020 |
| Functional T436K SNP in DBP is a predictor of serum 25 (OH) D: A replicate study in a young healthy adult population L Fu, D Wagner, HEC Hanwell, G Sidhom, J Zhu, BYL Wong, R Vieth, ... Clinical Biochemistry 41 (14-15), 1267, 2008 | 7 | 2008 |
